Figure 5.
Figure 5. Endothelial development in EphB4-deficient EBs is impaired. (A) EphB4–/– EBs display a less well defined vasculogenic morphology. ES cells of EphB4+/– (left) and EphB4–/– (right) were induced for vasculogenesis in the presence of VEGF, bFGF, EPO, and IL-6 in methylcellulose for 10 to 11 days. EBs were then transferred in collagen cultures for 3 to 6 days to develop sprouting EBs. (B) Capillary-like structures of EphB4+/– EBs were CD31+ by immunohistochemistry. EB cultures in collagen matrix were dehydrated and fixed in a methanol-acetone solution and stained with PE-conjugated antimouse PECAM1 (CD31; Pharmingen). Original magnification, × 4. (C) Total numbers of vascular-like EBs were significantly decreased in EphB4–/– EBs. EB in collagen matrix were analyzed for sprouting EB induction. Total EBs and capillary-like EBs (vascular EBs) were counted in EphB4+/– and EphB4–/– cultures. Error bars represent standard deviation (n = 9).

Endothelial development in EphB4-deficient EBs is impaired. (A) EphB4/ EBs display a less well defined vasculogenic morphology. ES cells of EphB4+/ (left) and EphB4/ (right) were induced for vasculogenesis in the presence of VEGF, bFGF, EPO, and IL-6 in methylcellulose for 10 to 11 days. EBs were then transferred in collagen cultures for 3 to 6 days to develop sprouting EBs. (B) Capillary-like structures of EphB4+/ EBs were CD31+ by immunohistochemistry. EB cultures in collagen matrix were dehydrated and fixed in a methanol-acetone solution and stained with PE-conjugated antimouse PECAM1 (CD31; Pharmingen). Original magnification, × 4. (C) Total numbers of vascular-like EBs were significantly decreased in EphB4/ EBs. EB in collagen matrix were analyzed for sprouting EB induction. Total EBs and capillary-like EBs (vascular EBs) were counted in EphB4+/ and EphB4/ cultures. Error bars represent standard deviation (n = 9).

Close Modal

or Create an Account

Close Modal
Close Modal